New Yorkers who bought certain generic prescription drugs from May 2009 through December 2019 may qualify for compensation under a $400 million multistate settlement with Sandoz and Fougera Pharmaceuticals. The deadline to submit a claim is March 8, 2027, according to New York Attorney General Letitia James.
The attorney general's announcement says James joined a bipartisan coalition of 47 other attorneys general in reaching the agreement. It stems from lawsuits accusing generic-drug makers of coordinating prices, supply and bids to reduce competition. The settlement does not mean every purchaser of a generic medicine is eligible for payment.
Consumers can check the covered-drug list and submit a claim at AGGenericDrugs.com, the settlement website identified by the attorney general's office. The claims administrator can also be reached at 1-866-290-0182 or info@aggenericdrugs.com. People should check their eligibility and the official instructions before providing purchase information.
The attorney general's office said the coalition's three lawsuits involve more than 100 generic drugs. The medications span tablets, capsules, creams and ointments used for conditions ranging from infections to diabetes, cancer, epilepsy and ADHD. The coalition alleges some coordinated price increases exceeded 1,000%; that figure is an allegation about the broader litigation, not a stated price change for every drug or consumer.
Under the Sandoz agreement, the companies will pay $320,560,180 plus interest over seven years, for a total of $400 million, the office said. Money is to be distributed to affected consumers in coalition jurisdictions. The announcement did not state how much any individual New York claimant will receive; that will depend on eligibility and the claims process.
Sandoz also agreed to antitrust compliance measures, including annual training for sales and management employees and a chief compliance officer. It will cooperate with the states in litigation that remains underway against other companies, according to the attorney general's office.
The coalition previously announced other settlements in the generic-drug cases, including with Glenmark Pharmaceuticals in July and with Lannett and Bausch in February. Those are separate agreements, and the claims announced for Sandoz have their own March 2027 deadline.
James urged New Yorkers who may have paid inflated prices to review the covered drugs and file a claim if they qualify. Consumers who need a paper form can request one from the claims administrator by phone or email.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to news@fingerlakes1.com.